Division of
GMP Publications, Inc.

ohn Cuspilich
Send Comments to QA/RA Editor

Food and Drug Assistance - Resources for Industry and Consumers

 

 

 
 

Condition - Disease

Links & Resources

- Add an Forum -

Acne - see Skin Care

ADD and ADHD

AIDS/HIV

Allergies

Alzheimer's

Arthritis

Asthma

Autism

Back Pain

Birth Control

Cancer - Breast

Cancer - Prostate

Cholesterol

Common Cold  |  Flu

Crohn's & Colitis

Dental Health

Diabetes

Diet & Nutrition

Ear Disorders

Epilepsy

Erectile Dysfunction

Hair Loss

Headache | Migraine

Heartburn

Heart Attacks

Hepatitis

Hemorrhoids

Kidney

Lyme Disease

Men's Health

MRSA

Multiple Sclerosis

Osteoporosis

Parkinson's

SARS

SIDS

Skin Care

Sleep Disorders

Smoking

Snoring

Stress | Depression

Stroke

Vitamins

Weight Control


 
 
Hair Loss and Hair Issues

Clinical Trials  |  Add a link  |  Regulations  |  Discussion Board  |  Ask the Nurse | Last Update January 1st. 2009  |  About FDA.COM  | Media Kit

Also called: Alopecia

Did you know that the average person has 5 million hairs? Hair grows all over your body except on your lips, palms and the soles of your feet. It takes about four months for healthy hair to grow an inch. Most hairs grow for up to six years and then fall out. New hairs grow in their place.

Men - and some women - lose hair as they grow older. You can also lose your hair if you have certain diseases, such as thyroid problems, diabetes or lupus. If you take certain medicines or have chemotherapy for cancer, you may also lose your hair. Other causes are a low protein diet, a family history or poor nutrition.

Start Here
 

 

Reference Links - Add a link

 

Clinical Trials - Add a clinical trial

 top
1
Recruiting
Alopecia Areata Registry
Conditions:
Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis;   Autoimmune Hair Loss;   Alopecia Partialis 
Intervention:
 
 
 

 
2
Recruiting
Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Condition:
Alopecia 
Interventions:
Drug: 7% (w/v) Tempol alcohol-based gel (MTS-01);   Drug: alcohol-based gel 
 
 

 
3
Recruiting
Efalizumab in the Treatment of Alopecia, Phase II
Condition:
Alopecia Totalis 
Intervention:
Drug: efalizumab 
 
 

 
4
Recruiting
Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss
Condition:
Female Pattern Hair Loss 
Interventions:
Drug: Spironolactone;   Drug: Minoxidil 
 
 

 
5
Recruiting
Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling
Conditions:
Alopecia;   Breast Cancer 
Intervention:
Device: elasto-gel cap 
 
 

 
6
Not yet recruiting
Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin
Condition:
Alopecia Areata 
Intervention:
Drug: Intracutaneous injections of Botulinum Toxin A (Botox), 0.1 cc per injection site, which equals 10 units 
 
 

 
7
Not yet recruiting
 

 
8
Recruiting
Alopecia Areata Registry and Immunogenetic Mechanisms
Condition:
Alopecia Areata 
Intervention:
Behavioral: questionnaires 
 
 

 
9
Recruiting
Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL in Patients With Alopecia Areata
Condition:
Alopecia Areata 
Intervention:
Drug: Triamcinolone Acetonide 10 mg/mL 
 
 

 
10
Recruiting
Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions
Conditions:
Atopic Dermatitis;   Psoriasis;   Alopecia;   Mycosis Fungoides;   Urticaria;   Dermatoses;   Stretch Marks 
Intervention:
Procedure: UVA1 and UVB Irradiation 
 
 

 
11
Not yet recruiting
Reflexology's Effect on Polycystic Ovary Syndrome (PCOS)
Condition:
Polycystic Ovary Syndrome 
Intervention:
Other: Reflexology 
 
 

 
12
Not yet recruiting
Reflexology's Effect on Polycystic Ovary Syndrome: A Pilot Study
Condition:
Polycystic Ovary Syndrome 
Intervention:
Other: Reflexology 
 
 

 
13
Recruiting
Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib
Conditions:
Cancer-Related Problem/Condition;   Lung Cancer 
Interventions:
Drug: erlotinib hydrochloride;   Procedure: laboratory biomarker analysis;   Procedure: questionnaire administration 
 
 

 
14
Recruiting
A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma
Condition:
Recurrent or Progressive Malignant Glioma 
Intervention:
Drug: ANG1005 
 
 

 
15
Recruiting
A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer
Condition:
Advanced Solid Tumors With and Without Brain Metastases 
Intervention:
Drug: ANG1005 
 
 

 
16
Recruiting
Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects
Conditions:
Breast Cancer;   Arthralgia;   Osteoporosis 
Intervention:
Drug: Testosterone 
 
 

 
17
Recruiting
Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach
Conditions:
Non-Hodgkin's Lymphoma;   Cancer 
Interventions:
Drug: Vincristine;   Drug: VP-16;   Drug: Rituximab;   Drug: Dexamethasone;   Drug: Levofloxacin 
 
 

 
18
Recruiting
Genetic Analysis of Hereditary Disorders of Hearing and Balance
Conditions:
Sensorineural Hearing Loss;   Hearing Disorder;   Vestibular Disease 
Intervention:
 
 
 

 
19
Recruiting
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts
Conditions:
Sensorineural Hearing Loss;   Cytomegalovirus Infection 
Intervention:
 
 
 

 
20
Recruiting